Huadong Medicine Co., Ltd

SZSE:000963 Stock Report

Market Cap: CN¥57.4b

Huadong Medicine Balance Sheet Health

Financial Health criteria checks 6/6

Huadong Medicine has a total shareholder equity of CN¥22.5B and total debt of CN¥1.8B, which brings its debt-to-equity ratio to 8.1%. Its total assets and total liabilities are CN¥34.5B and CN¥12.0B respectively. Huadong Medicine's EBIT is CN¥3.7B making its interest coverage ratio 175.8. It has cash and short-term investments of CN¥3.6B.

Key information

8.1%

Debt to equity ratio

CN¥1.81b

Debt

Interest coverage ratio175.8x
CashCN¥3.56b
EquityCN¥22.49b
Total liabilitiesCN¥11.98b
Total assetsCN¥34.47b

Recent financial health updates

Recent updates

Huadong Medicine Co., Ltd (SZSE:000963) Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Apr 21
Huadong Medicine Co., Ltd (SZSE:000963) Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Market Cool On Huadong Medicine Co., Ltd's (SZSE:000963) Earnings

Apr 08
Market Cool On Huadong Medicine Co., Ltd's (SZSE:000963) Earnings

Is Huadong Medicine (SZSE:000963) A Risky Investment?

Mar 16
Is Huadong Medicine (SZSE:000963) A Risky Investment?

Financial Position Analysis

Short Term Liabilities: 000963's short term assets (CN¥19.2B) exceed its short term liabilities (CN¥10.9B).

Long Term Liabilities: 000963's short term assets (CN¥19.2B) exceed its long term liabilities (CN¥1.1B).


Debt to Equity History and Analysis

Debt Level: 000963 has more cash than its total debt.

Reducing Debt: 000963's debt to equity ratio has reduced from 16.5% to 8.1% over the past 5 years.

Debt Coverage: 000963's debt is well covered by operating cash flow (203.6%).

Interest Coverage: 000963's interest payments on its debt are well covered by EBIT (175.8x coverage).


Balance Sheet


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.